Your browser doesn't support javascript.
loading
Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein.
Vassell, Russell; He, Yong; Vennakalanti, Prasad; Dey, Antu K; Zhuang, Min; Wang, Wei; Sun, Yide; Biron-Sorek, Zohar; Srivastava, Indresh K; LaBranche, Celia C; Montefiori, David C; Barnett, Susan W; Weiss, Carol D.
Afiliación
  • Vassell R; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • He Y; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Vennakalanti P; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Dey AK; Novartis Vaccines and Diagnostics, Cambridge, Massachusetts, United States of America.
  • Zhuang M; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America; Department of Microbiology, Harbin Medical University, Heilongjiang, China.
  • Wang W; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
  • Sun Y; Novartis Vaccines and Diagnostics, Cambridge, Massachusetts, United States of America.
  • Biron-Sorek Z; Novartis Vaccines and Diagnostics, Cambridge, Massachusetts, United States of America.
  • Srivastava IK; Novartis Vaccines and Diagnostics, Cambridge, Massachusetts, United States of America.
  • LaBranche CC; Department of Surgery, Duke Medical Center, Durham, North Carolina, United States of America.
  • Montefiori DC; Department of Surgery, Duke Medical Center, Durham, North Carolina, United States of America.
  • Barnett SW; Novartis Vaccines and Diagnostics, Cambridge, Massachusetts, United States of America.
  • Weiss CD; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
PLoS One ; 10(6): e0128562, 2015.
Article en En | MEDLINE | ID: mdl-26087072
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Sintéticas / Anticuerpos Anti-VIH / Proteína gp41 de Envoltorio del VIH / Proteínas Virales de Fusión / VIH-1 / Vacunas contra el SIDA Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Sintéticas / Anticuerpos Anti-VIH / Proteína gp41 de Envoltorio del VIH / Proteínas Virales de Fusión / VIH-1 / Vacunas contra el SIDA Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos